Literature DB >> 19556102

An initial assessment of the psychometric properties of the Complicated Grief Questionnaire for People with Intellectual Disabilities (CGQ-ID).

Suzanne Guerin1, Philip Dodd, Janette Tyrell, John McEvoy, Sarah Buckley, John Hillery.   

Abstract

Given the research evidence that people with intellectual disability (ID) do grieve following bereavement, the present study aimed to describe and gather preliminary psychometric data for a version of the Inventory of Complicated Grief [Prigerson, H. G., Maciejewski, P. K., Reynolds, C. F., Bierhals, A. J., Newsom, J. T., Fasiczka, A., et al. (1995). Inventory of Complicated Grief: A scale to measure maladaptive symptoms of loss. Psychiatry Research, 59, 65-79] adapted for use with this population. Carers completed the Complicated Grief Questionnaire for People with ID (CGQ-ID) for 76 individuals with ID, half of whom had experienced a parental bereavement within the last 2 years. The final scale and subscales (Separation Distress and Traumatic Grief) showed very good internal and inter-rater reliability and distinguished between the two groups. While the findings suggest that the CGQ-ID is suitable for identifying complicated grief-type symptoms among adults with ID, further research must be conducted to ascertain whether the findings can be replicated.

Entities:  

Mesh:

Year:  2009        PMID: 19556102     DOI: 10.1016/j.ridd.2009.05.002

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  2 in total

1.  Relationship between family quality of life and day occupations of young people with Down syndrome.

Authors:  Kitty-Rose Foley; Sonya Girdler; Jenny Downs; Peter Jacoby; Jenny Bourke; Nick Lennox; Stewart Einfeld; Gwynnyth Llewellyn; Trevor R Parmenter; Helen Leonard
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-12       Impact factor: 4.328

Review 2.  Bereavement and complicated grief.

Authors:  M Katherine Shear; Angela Ghesquiere; Kim Glickman
Journal:  Curr Psychiatry Rep       Date:  2013-11       Impact factor: 5.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.